Status:
COMPLETED
The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients
Lead Sponsor:
Dr. Nicole Culos-Reed
Conditions:
Multiple Myeloma
Hematologic Neoplasms
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although physical activity (PA) is commonly used to manage symptoms and enhance quality of life (QOL) in cancer survivors, relatively little is known regarding the benefits in advanced multiple myelom...
Detailed Description
While the introduction of novel and more effective treatments has seen improved survival in multiple myeloma (MM), the aggressive nature of the disease and these corresponding agents can have a debili...
Eligibility Criteria
Inclusion
- diagnosed with advanced (Durie-Salmon stage II-III) multiple myeloma
- 18 years of age or older and given a survival prognosis greater than 6 months
- stable hemoglobin level of ≥80g/L as measured within 2 weeks of enrollment
- no active infections at the time of enrollment.
Exclusion
- refusal of informed consent
- geographically inaccessible
- non-English speaking
- co-morbidities that interfere with participation (i.e., severe mobility issues or cognitive impairments)
- known or active history of substance abuse
Key Trial Info
Start Date :
March 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2018
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04303091
Start Date
March 2 2018
End Date
December 20 2018
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N 1N4